-
10/1/2008
PdxBio™ subsidiary Louisville Bioscience, Inc. announces an exclusive licensing agreement with the University of Louisville for novel screening and diagnostic technologies.
-
10/15/2007
PdxBio™ licenses materials from OHSU to build genetic tests for Macular Degeneration (AMD) and heart defects (CRELD1 mutations).
-
8/07/2007
PdxBio™ awarded NIH Phase II SBIR grant for development of multiplex SNP assays.
-
4/23/2007
PdxBio™ awarded NIH Phase I SBIR grant for development of multiplex SNP assays.
-
8/14/2006
PdxBio™ awarded NIH Phase II SBIR grant to study cross-hybridization in multiplex DNA hybridization reactions.
-
8/10/2005
PdxBio™ awarded NIH Phase I SBIR grant to study cross-hybridization in multiplex DNA hybridization reactions.
Copyright 2007 © Portland Bioscience, Inc. All rights reserved.